Construct: ORF TRCN0000491520
Construct Description:
- Construct Type:
- ORF
- Other Identifiers:
- ORF020446.2_s317c1
- DNA Barcode:
- TTTCTTCGCCTCATCTCCCTTGTC
- Epitope Tag:
- V5 (not translated due to prior stop codon)
- Notes:
- Has stop codon in insert
Originally Annotated References:
- Gene:
- FGFR2 (2263)
Vector Information:
- Vector Backbone:
- pLX_317
- Pol II Cassette 1:
- SV40-PuroR
- Pol II Cassette 2:
- EF1a-TRCN0000491520
- Selection Marker:
- PuroR
- Visible Reporter:
- n/a
- Epitope Tag:
- V5
Current transcripts matched by this ORF:
Taxon | Gene | Symbol | Description | Transcript | Nuc. Match %[?]A simple nucleotide-based global alignment percentage, calculated as follows: total nt. matches ---------------------------------- aligned length (incl. gaps) |
Prot. Match %[?]A simple amino acid-based global alignment percentage, calculated as follows: total aa. matches ---------------------------------- aligned length (incl. gaps) |
Match Diffs[?]This field may contain sequence annotations in HGVS format. For more information about HGVS annotations, please refer to the HGVS Quick Reference Guide. | |
---|---|---|---|---|---|---|---|---|
1 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_001320658.2 | 99.9% | 100% | 696A>G |
2 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_000141.4 | 99.7% | 99.7% | 696A>G;1282_1287delGTAACA |
3 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_022970.3 | 96.5% | 96.4% | (many diffs) |
4 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_006717708.3 | 94.5% | 94.5% | (many diffs) |
5 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_017015921.2 | 93.3% | 93.3% | (many diffs) |
6 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_017015920.2 | 90.3% | 90.1% | (many diffs) |
7 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_006717710.4 | 90% | 89.9% | (many diffs) |
8 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_001144913.1 | 90% | 89.9% | (many diffs) |
9 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_023029.2 | 88.8% | 88.9% | 107_108ins267;429A>G;1015_1020delGTAACA |
10 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_024447889.1 | 87% | 87.1% | 1_57del;164_165ins267;486A>G |
11 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_024447887.1 | 86.8% | 86.9% | (many diffs) |
12 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_001144914.1 | 86% | 86.1% | 696A>G;747_748ins336;946_951delGTAACA |
13 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_001144917.2 | 86% | 86% | 696A>G;937_938ins342 |
14 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_001144918.2 | 85.9% | 85.8% | 109_110ins345;351A>G |
15 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_001144916.1 | 85.7% | 85.6% | 109_110ins345;351A>G;937_942delGTAACA |
16 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_001144915.1 | 84% | 82.9% | (many diffs) |
17 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_024447888.1 | 84% | 83.9% | (many diffs) |
18 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_024447890.1 | 83.8% | 83.7% | (many diffs) |
19 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_017015924.2 | 83.7% | 83.6% | (many diffs) |
20 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_024447891.1 | 80.7% | 80.5% | (many diffs) |
21 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_017015925.2 | 79.6% | 79.4% | (many diffs) |
22 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_001144919.2 | 79.3% | 79.1% | (many diffs) |
23 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_001320654.1 | 71% | 69.1% | (many diffs) |
24 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_024447892.1 | 52.2% | 52.2% | 0_1ins1170;112_117delGTAACA |
25 | human | 2263 | FGFR2 | fibroblast growth factor re... | NR_073009.2 | 50.9% | (many diffs) | |
26 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_011241674.2 | 89.5% | 95.3% | (many diffs) |
27 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | NM_010207.2 | 89.3% | 95.1% | (many diffs) |
28 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_006507350.3 | 86.5% | 92.1% | (many diffs) |
29 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_006507349.2 | 86.3% | 91.9% | (many diffs) |
30 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_011241673.2 | 86.3% | 91.9% | (many diffs) |
31 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_017321975.1 | 86.3% | 91.9% | (many diffs) |
32 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_017321977.1 | 85.8% | 91% | (many diffs) |
33 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_017321976.1 | 82.8% | 87.8% | (many diffs) |
34 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_006507352.2 | 82.6% | 87.6% | (many diffs) |
35 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_011241675.2 | 79.5% | 85.2% | (many diffs) |
36 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | NM_001347638.1 | 77% | 82.9% | (many diffs) |
37 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_006507357.3 | 76.9% | 82.7% | (many diffs) |
38 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_011241676.2 | 76.7% | 82.2% | (many diffs) |
39 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_006507354.3 | 76.5% | 82% | (many diffs) |
40 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_011241677.2 | 74.1% | 79.7% | (many diffs) |
41 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | NM_201601.2 | 74% | 79.5% | (many diffs) |
42 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XR_001785477.1 | 33.8% | (many diffs) | |
43 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XR_001785478.1 | 33.3% | (many diffs) |
Sequence Information
Note: uppercase bases indicate empirically verified sequence.
- ORF start:
- 72
- ORF end:
- 2529
- ORF length:
- 2457
- Sequence:
-
1 tcttccattt caggtgtcgt gaggctagca tcgattgatc aacaagtttg tacaaaaaag 61 caggcttcac catggtcagc tggggtcgtt tcatctgcct ggtcgtggtc accatggcaa 121 ccttgtccct ggcccggccc tccttcagtt tagttgagga taccacatta gagccagaag 181 agccaccaac caaataccaa atctctcaac cagaagtgta cgtggctgcg ccaggggagt 241 cgctagaggt gcgctgcctg ttgaaagatg ccgccgtgat cagttggact aaggatgggg 301 tgcacttggg gcccaacaat aggacagtgc ttattgggga gtacttgcag ataaagggcg 361 ccacgcctag agactccggc ctctatgctt gtactgccag taggactgta gacagtgaaa 421 cttggtactt catggtgaat gtcacagatg ccatctcatc cggagatgat gaggatgaca 481 ccgatggtgc ggaagatttt gtcagtgaga acagtaacaa caagagagca ccatactgga 541 ccaacacaga aaagatggaa aagcggctcc atgctgtgcc tgcggccaac actgtcaagt 601 ttcgctgccc agccgggggg aacccaatgc caaccatgcg gtggctgaaa aacgggaagg 661 agtttaagca ggagcatcgc attggaggct acaaggtacg aaaccagcac tggagcctca 721 ttatggaaag tgtggtccca tctgacaagg gaaattatac ctgtgtggtg gagaatgaat 781 acgggtccat caatcacacg taccacctgg atgttgtgga gcgatcgcct caccggccca 841 tcctccaagc cggactgccg gcaaatgcct ccacagtggt cggaggagac gtagagtttg 901 tctgcaaggt ttacagtgat gcccagcccc acatccagtg gatcaagcac gtggaaaaga 961 acggcagtaa atacgggccc gacgggctgc cctacctcaa ggttctcaag gccgccggtg 1021 ttaacaccac ggacaaagag attgaggttc tctatattcg gaatgtaact tttgaggacg 1081 ctggggaata tacgtgcttg gcgggtaatt ctattgggat atcctttcac tctgcatggt 1141 tgacagttct gccagcgcct ggaagagaaa aggagattac agcttcccca gactacctgg 1201 agatagccat ttactgcata ggggtcttct taatcgcctg tatggtggta acagtcatcc 1261 tgtgccgaat gaagaacacg accaagaagc cagacttcag cagccagccg gctgtgcaca 1321 agctgaccaa acgtatcccc ctgcggagac aggtttcggc tgagtccagc tcctccatga 1381 actccaacac cccgctggtg aggataacaa cacgcctctc ttcaacggca gacaccccca 1441 tgctggcagg ggtctccgag tatgaacttc cagaggaccc aaaatgggag tttccaagag 1501 ataagctgac actgggcaag cccctgggag aaggttgctt tgggcaagtg gtcatggcgg 1561 aagcagtggg aattgacaaa gacaagccca aggaggcggt caccgtggcc gtgaagatgt 1621 tgaaagatga tgccacagag aaagaccttt ctgatctggt gtcagagatg gagatgatga 1681 agatgattgg gaaacacaag aatatcataa atcttcttgg agcctgcaca caggatgggc 1741 ctctctatgt catagttgag tatgcctcta aaggcaacct ccgagaatac ctccgagccc 1801 ggaggccacc cgggatggag tactcctatg acattaaccg tgttcctgag gagcagatga 1861 ccttcaagga cttggtgtca tgcacctacc agctggccag aggcatggag tacttggctt 1921 cccaaaaatg tattcatcga gatttagcag ccagaaatgt tttggtaaca gaaaacaatg 1981 tgatgaaaat agcagacttt ggactcgcca gagatatcaa caatatagac tattacaaaa 2041 agaccaccaa tgggcggctt ccagtcaagt ggatggctcc agaagccctg tttgatagag 2101 tatacactca tcagagtgat gtctggtcct tcggggtgtt aatgtgggag atcttcactt 2161 tagggggctc gccctaccca gggattcccg tggaggaact ttttaagctg ctgaaggaag 2221 gacacagaat ggataagcca gccaactgca ccaacgaact gtacatgatg atgagggact 2281 gttggcatgc agtgccctcc cagagaccaa cgttcaagca gttggtagaa gacttggatc 2341 gaatTCTCAC TCTCACAACC AATGAGGAAT ACTTGGACCT CAGCCAACCT CTCGAACAGT 2401 ATTCACCTAG TTACCCTGAC ACAAGAAGTT CTTGTTCTTC AGGAGATGAT TCTGTTTTTT 2461 CTCCAGACCC CATGCCTTAC GAACCATGCC TTCCTCAGTA TCCACACATA AACGGCAGTG 2521 TTAAAACATA GGACCCAGCT TTCTTGTACA AAGTGGTTGA TATCGGTAAG CCTATCCCTA 2581 ACCCTCTCCT CGGTCTCGAT TCTACGTAGT AATGAACTAG TCCGTAACTT GAAAGTATTT 2641 CGATTTCTTG GCTTTATATA TCTTGTGGAA AGGACGATTT CTTCGCCTCA TCTCCCTTGT 2701 CACGCGTTAA GTCgacaatc aacctctgga ttacaaaatt tgtgaaagat t